全文获取类型
收费全文 | 3731篇 |
免费 | 192篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 219篇 |
妇产科学 | 39篇 |
基础医学 | 219篇 |
口腔科学 | 6篇 |
临床医学 | 663篇 |
内科学 | 613篇 |
皮肤病学 | 6篇 |
神经病学 | 48篇 |
特种医学 | 148篇 |
外科学 | 148篇 |
综合类 | 741篇 |
预防医学 | 444篇 |
眼科学 | 1篇 |
药学 | 460篇 |
7篇 | |
中国医学 | 157篇 |
肿瘤学 | 22篇 |
出版年
2024年 | 6篇 |
2023年 | 54篇 |
2022年 | 123篇 |
2021年 | 194篇 |
2020年 | 258篇 |
2019年 | 94篇 |
2018年 | 111篇 |
2017年 | 105篇 |
2016年 | 152篇 |
2015年 | 116篇 |
2014年 | 307篇 |
2013年 | 246篇 |
2012年 | 256篇 |
2011年 | 279篇 |
2010年 | 243篇 |
2009年 | 159篇 |
2008年 | 163篇 |
2007年 | 167篇 |
2006年 | 169篇 |
2005年 | 140篇 |
2004年 | 124篇 |
2003年 | 123篇 |
2002年 | 61篇 |
2001年 | 49篇 |
2000年 | 36篇 |
1999年 | 35篇 |
1998年 | 29篇 |
1997年 | 23篇 |
1996年 | 12篇 |
1995年 | 19篇 |
1994年 | 18篇 |
1993年 | 10篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 12篇 |
1989年 | 6篇 |
1988年 | 6篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 4篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1976年 | 1篇 |
排序方式: 共有3954条查询结果,搜索用时 15 毫秒
31.
目前我国由2019新型冠状病毒(SARS-CoV-2)引起的肺炎疫情仍在持续,抗疫形势仍很严峻。新型冠状病毒肺炎(COVID-19)潜伏期较长、传染能力强、人群普遍易感,给医护人员、患者和人民群众都造成了严重威胁。耳鼻咽喉头颈外科中的喉癌和下咽癌患者在疫情下仍需进行限期处理,因此在做好COVID-19排查和防控工作后,合理选择治疗方式,根据不同的风险等级,做好医务人员自身的防护措施,协调手术各方,合理有序地开展手术治疗及患者术后的规范化管理,对疫情下救治喉癌和下咽癌患者具有重要意义。 相似文献
32.
目的探讨新型冠状病毒肺炎(COVID 19)疫情下耳鼻咽喉头颈外科喉镜室如何做好防护工作,在保证临床诊疗工作顺利完成的同时保护好医务人员及患者健康、避免院内交叉感染。方法本研究查阅相关资料并总结医院的疫情防控经验及应对策略,在患者合理分流、喉镜室工作环境的布置及工作人员的个人防护、喉镜检查前的准备工作、检查中的操作流程及注意事项及检查后的清洁消毒工作等方面做好疫情期间周详合理的工作安排。结果疫情期间,耳鼻咽喉头颈外科喉镜室每日临床工作顺利完成,所有医务人员及患者均未感染新型冠状病毒,也未出现其他院内交叉感染。结论耳鼻咽喉头颈外科喉镜室的防护策略合理有效,能够在完成临床诊疗工作的同时有效保护医患的健康。 相似文献
33.
《Journal of microbiology, immunology, and infection》2020,53(3):481-484
We reported two cases with community-acquired pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who returned from Wuhan, China in January, 2020. The reported cases highlight non-specific clinical presentations of 2019 novel coronavirus disease (COVID-19) as well as the importance of rapid laboratory-based diagnosis. 相似文献
34.
本文报告一例妊娠晚期合并新型冠状病毒肺炎(COVID-19)危重型孕妇。患者32岁,孕35周+2因"咽痛4 d,发热3 h"入院。入院前曾至湖北孝感应城,回家隔离期间发病。入院后病情进展迅速,7 h后出现左侧胸背部疼痛、气促、头晕,迅即出现呼吸衰竭、感染性休克。考虑病情严重,且有2次剖宫产史,行紧急子宫下段剖宫产术。术前血气分析示呼吸衰竭、呼吸性酸中毒合并代谢性酸中毒。术中娩出一男婴,2700 g,1 min Apgar评分1分(心率20次/min),经复苏抢救,5和10 min评分均为1分,家属放弃抢救后死亡。产妇术后气管插管呼吸机维持,同时给予其他支持治疗。入院时的新型冠状病毒核酸检测结果于分娩后报告为阳性,遂转入定点医院治疗。患者术后26 d体外膜肺氧合脱机成功,术后36 d脱离呼吸机,进入康复阶段。 相似文献
35.
Naohiro Oda Takahiro Taki Reo Mitani Ichiro Takata 《Journal of infection and chemotherapy》2021,27(5):751-754
Herein, we report the case of a 74-year-old man diagnosed with Legionella pneumonia detected by Loop-Mediated Isothermal Amplification (LAMP) method, which was suspected to have been transmitted from the potting soil. Legionella longbeachae was identified in the sputum culture. The patient was intubated and maintained on mechanical ventilation. Antimicrobial therapy with azithromycin was also administered. His symptoms were resolved and he was discharged after 26 days of hospitalization. Legionella longbeachae pneumonia rarely occurs in Japan, and published literature of Legionella longbeachae pneumonia cases in Japan was reviewed. Patients with severe pneumonia exposed to potting soils, but with negative urinary antigen test results, should be examined by LAMP method. 相似文献
36.
37.
《Journal of microbiology, immunology, and infection》2021,54(4):748-751
IntroductionThe novel coronavirus disease (COVID-19) could cause a severe acute respiratory infectious disease, showing a high mortality rate of 12–45% among cases who required intensive care unit admission. COVID-19 pneumoniaPatients and methodsFor the purpose of identifying clinical manifestations and radiological findings of COVID-19 pneumonia, we reviewed all cases of COVID-19 pneumonia which were published by the homepage of the Japanese Association for Infectious Diseases from Feb 5 2020 until April 30 2020, including our cases. All patients were diagnosed based on positive results of the novel coronavirus-real-time RT-PCR with chest computed tomography (CT) findings.ResultsA total of 92 patients were enrolled in this study. The median age was 66 years (range 16–92 years). For all, 50 (54%) were males. The most common underlying disease was hypertension in 32 (36%). Any comorbidity was seen in 60 (67%). The mortality rate was 4 (6%). In terms of clinical symptoms on an initial visit, fever and cough were confirmed in 66 (72%) and 37 (40%). Forty-three (47%) had no respiratory symptoms. As for radiological findings by chest CT scan, ground-glass opacities (GGO)s, peripheral distribution, bilateral lung involvements were seen in 88 (96%), 76 (83%) and 78 (85%), respectively.ConclusionIt is difficult to diagnose as COVID-19 pneumonia due to poor respiratory symptoms. Chest CT findings typically show GGO, peripheral and bilateral shadows. Patients should have chest CT performed if suspected for early diagnosis and therapeutic intervention, resulting in a favorable outcome and prevention of secondary nosocomial transmitted infection. 相似文献
38.
肺炎是呼吸系统疾病中的常见疾病,发病率高,可伴有多种并发症,严重时可危及生命健康。肺炎患者多伴有肠道菌群失调,表现为有益菌减少,且益生菌可通过“肠-肺轴”影响肺部免疫参与肺炎的发生发展。中医以“肺”与“大肠”两者之间的生理及病理关系为基础,通过整体观念和辨证论治发挥了治疗肺炎的独特的优势。近年来,许多研究表明中医药在治疗肺炎的过程中具有改善肠道微生态作用,但肺炎的中医辨证分型与肠道菌群的相关性尚不明确。本文从中医辨证分型论治肺炎的角度出发,总结不同辨证分型的肺炎与肠道菌群结构特征,阐述中医治疗肺炎过程中对于益生菌的调节作用和“证型—中药—益生菌”的对应关系。通过讨论益生菌在防治肺炎中的关键作用,展望中医辩证联合益生菌治疗肺炎的应用前景,以期为肺炎的防治提供新思路和新靶点,也为将来指导不同肺炎证型患者选择适合的中药及益生菌提供理论依据。 相似文献
39.
Benjamin J. Ereshefsky Majdi N. Al-Hasan Yevgeniya Gokun Craig A. Martin 《Journal of chemotherapy (Florence, Italy)》2017,29(1):30-37
We sought to compare clinical cure on day 7 and a 28-day all-cause mortality in patients who received an anti-pseudomonal ß-lactam with a fluoroquinolone or an aminoglycoside for treatment of nosocomial bacteremia or pneumonia due to Gram-negative bacilli while in the ICU. This retrospective cohort study was conducted in critically ill patients at an academic medical centre from January 2005 to August 2011. A total of 129 patients (83 receiving aminoglycoside and 46 receiving fluoroquinolone combinations) were included. Seven-day clinical cure rates were 74% and 72% for fluoroquinolone and aminoglycoside groups, respectively (p = 0.84). There was no significant difference in the odds of clinical cure with a fluoroquinolone as compared to an aminoglycoside combination (adjusted odds ratio 2.4, 95% confidence interval [CI] 0.7–9.0). There was no significant difference in 28-day mortality in patients who received a fluoroquinolone or an aminoglycoside combination (22% vs. 18%, adjusted hazard ratio 0.82, 95% CI 0.29–2.28). 相似文献
40.
A. Prevotat C. Rouyer P. Gosset E. Kipnis K. Faure B. Guery 《Médecine et maladies infectieuses》2018,48(2):103-113